Vitamin D Status, Vitamin D Receptor Gene Variants, and Hypertension Risk
Vitamin D Status, Vitamin D Receptor Gene Variants, and Hypertension Risk
批准号:
8130777
负责人:
Lu Wang
金额:
$8.95万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-20 至 2012-09-30
关键词:
AddressAldosteroneAwardBindingBiochemical GeneticsBiochemical MarkersBiologicalBiological MarkersBlood PressureCandidate Disease GeneCardiovascular DiseasesCessation of lifeChronic DiseaseCollaborationsDataDatabasesDevelopmentEpidemiologic StudiesEpidemiologistEpidemiologyEvaluationFosteringGenesGeneticGenetic MarkersGenetic PolymorphismGenetic VariationGenotypeGoalsHaplotypesHealthHealth ProfessionalHigh PrevalenceHypertensionHypotensionInterventionInvestigationKnowledgeLinkMentorsMetabolismMixed Function OxygenasesNested Case-Control StudyNutritionalOutcomePathway interactionsPhasePhysiciansPlasmaPopulationPrevalencePrimary PreventionProspective StudiesPublic HealthRXRRXRA geneRXRB geneRXRG geneReceptor GeneRecommendationRenin-Angiotensin-Aldosterone SystemResearchResearch ActivityResearch PersonnelResearch Project GrantsResearch TrainingResourcesRiskRoleSignal PathwaySolidTestingTrainingTraining and EducationVariantVitamin DVitamin D-Binding ProteinVitamin D2Vitamin D3 ReceptorWomanWomen&aposs Healthbasecareer developmentcohortdesignfollow-upgenetic associationgenetic epidemiologygenetic variantgenome wide association studyhigh riskhypertension preventionimprovedmalemennormotensivenovel strategiesnutritionnutritional epidemiologypreventprogramsprospectivepublic health relevancerandomized trialresearch facilityresearch studyskills
中文摘要
描述(由申请人提供):此K99/R00提案的目标是为申请人建立一个有指导的独立研究计划,以全面调查维生素D在女性和男性高血压发展中的营养,生化和遗传基础。寻找新的策略来预防高血压,这是美国最普遍的慢性疾病,对公共卫生至关重要。越来越多的证据表明,维生素D是一种很有前途的预防高血压的营养剂。然而,关于维生素D与高血压关系的流行病学研究仍然有限。很少有前瞻性研究调查了基线循环25(OH)-维生素D (25(OH)D),维生素D状态的生化标记物与随后发生高血压的风险之间的关系。到目前为止,遗传流行病学研究只测试了维生素D受体(VDR)基因的少数多态性,在维生素D途径的许多基因中,与血压(BP)或高血压有关。此外,循环维生素D和维生素D通路基因多态性对高血压风险的潜在相互作用在很大程度上尚未被探索。因此,我们将在两个大型前瞻性队列中调查这些关联:妇女健康研究和医生健康研究。本奖项申请人在心血管疾病(CVD)流行病学方面具有扎实的教育和培训背景,并可获得丰富的研究、设施和合作资源。申请人目前的目标是提高她在遗传流行病学研究方面的知识和技能。她的长期目标是成为一名独立的流行病学家,研究与高血压和其他心血管疾病相关结果发展中营养因子代谢和功能相关的生化和遗传标记。在K99阶段,申请人将通过教学课程、指导研究、参加研讨会和技能实践,接受遗传流行病学方面的重点培训。申请人还将对血浆25(OH)D和维生素D途径的遗传变异(候选基因包括VDR、CYP27B1、CYP24A1、GC、RXRA、RXRB和RXRG)与BP和高血压的关系进行初步分析。在R00阶段,申请人将进一步扩展她的研究到两个专门设计的巢式高血压病例对照研究,评估基线血浆25(OH)D与随后高血压风险之间的前瞻性关联,调查潜在的机制,并探索潜在的基因-生物标志物相互作用。本研究结果将大大提高我们对维生素D在高血压发生中的作用的认识,并有助于优化高血压预防的干预策略。同时,集中的培训和研究将为申请人提供一个独特的机会,将遗传流行病学与她目前在心血管疾病和营养流行病学方面的研究结合起来,极大地促进她的职业发展,成为一名独立的高血压和心血管疾病发展中的营养、代谢和遗传学研究者。
英文摘要
DESCRIPTION (provided by applicant): The goal of this K99/R00 proposal is to build a mentored and independent research program for the applicant to comprehensively investigate the nutritional, biochemical, and genetic basis for vitamin D in the development of hypertension in women and men. Finding novel strategies to prevent hypertension, the most prevalent chronic disease in the U.S., is of critical public health importance. Accumulating evidence suggest that vitamin D is a promising nutritional agent for hypertension prevention. However, epidemiologic studies of vitamin D in relation to hypertension remain limited. Few prospective studies have examined the association between baseline circulating 25(OH)-vitamin D (25(OH)D), the biochemical marker of vitamin D status, and the subsequent risk of developing hypertension. Genetic epidemiologic studies to date have only tested a few polymorphisms in the vitamin D receptor (VDR) gene, among many genes in the vitamin D pathway, for association with blood pressure (BP) or hypertension. Moreover, the potential interaction of circulating vitamin D and vitamin D pathway gene polymorphisms on the risk of hypertension is largely unexplored. We will therefore investigate these associations in two large prospective cohorts: the Women's Health Study and the Physicians' Health Study. The applicant of this award has solid education and training background in cardiovascular disease (CVD) epidemiology and has access to rich research, facilities, and collaboration resources. The current goal of the applicant is to advance her knowledge and skills in genetic epidemiology research. Her long-term goal is to become an independent epidemiologist that investigates the biochemical and genetic markers relevant to the metabolism and functionality of nutritional factors in the development of hypertension and other CVD-related outcomes. During the K99 phase, the applicant will receive focused training in genetic epidemiology through didactic coursework, mentored research, seminars participation, and skill practice. The applicant will also conduct initial analyses of plasma 25(OH)D and genetic variants in vitamin D pathway (candidate genes including VDR, CYP27B1, CYP24A1, GC, RXRA, RXRB, and RXRG) in relation to BP and hypertension. During the R00 phase, the applicant will further extend her research to two specifically designed nested case-control studies of hypertension, assess prospective association between baseline plasma 25(OH)D and subsequent risk of hypertension, investigate the underlying mechanisms, as well as explore the potential gene-biomarker interactions. Findings from this study will substantially improve our understanding on the role of vitamin D in the development of hypertension and help optimize intervention strategy for hypertension prevention. Meanwhile the focused training and research together will offer the applicant a unique opportunity to integrate genetic epidemiology with her current research in CVD and nutritional epidemiology and greatly foster her career development to become an independent investigator on nutrition, metabolism, and genetics in the development of hypertension and CVD.
PUBLIC HEALTH RELEVANCE: The proposed research project will substantially improve our understanding regarding the role of vitamin D in the development of hypertension, help identify high risk population and optimize intervention strategy, and provide basis for public health recommendations on the optimal vitamin D status for primary prevention of hypertension and other cardiovascular disease-related outcomes.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.2165/11595400-000000000-00000
发表时间:
2012-04-01
期刊:
American journal of cardiovascular drugs : drugs, devices, and other interventions
影响因子:
--
作者:
[Wang L, Manson JE, Sesso HD]
通讯作者:
Sesso HD
Role of BAP1/ASXL3 complex in transcriptional regulation and development-ADMIN SUPPL for Equipment
-
批准号:10799150
-
项目类别:
-
资助金额:$20.54万
-
财政年份:2022
-
负责人:Lu Wang
-
依托单位:
A Phenotypical Brain Organoids for Neurodevelopmental Disorders
-
批准号:10676198
-
项目类别:
-
资助金额:$10.55万
-
财政年份:2022
-
负责人:Lu Wang
-
依托单位:
A Phenotypical Brain Organoids for Neurodevelopmental Disorders
-
批准号:10526025
-
项目类别:
-
资助金额:$10.56万
-
财政年份:2022
-
负责人:Lu Wang
-
依托单位:
Role of BAP1/ASXL3 complex in transcriptional regulation and development
-
批准号:10669750
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2022
-
负责人:Lu Wang
-
依托单位:
Mechanisms of enhancer regulation in aging and age-related diseases
-
批准号:10600490
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2020
-
负责人:Lu Wang
-
依托单位:
Mechanisms of enhancer regulation in aging and age-related diseases
-
批准号:9977548
-
项目类别:
-
资助金额:$9.94万
-
财政年份:2020
-
负责人:Lu Wang
-
依托单位:
Mechanisms of enhancer regulation in aging and age-related diseases
-
批准号:10852142
-
项目类别:
-
资助金额:$24.89万
-
财政年份:2020
-
负责人:Lu Wang
-
依托单位:
Mechanisms of enhancer regulation in aging and age-related diseases
-
批准号:10166757
-
项目类别:
-
资助金额:$9.94万
-
财政年份:2020
-
负责人:Lu Wang
-
依托单位:
Theoretical Modeling of the Vibrational Spectroscopy of Nucleic Acids
-
批准号:10330456
-
项目类别:
-
资助金额:$15.37万
-
财政年份:2019
-
负责人:Lu Wang
-
依托单位:
Plasma Lipid Markers and Cancer Risk
-
批准号:8548295
-
项目类别:
-
资助金额:$8.29万
-
财政年份:2012
-
负责人:Lu Wang
-
依托单位:
Vitamin D Status, Vitamin D Receptor Gene Variants, and Hypertension Risk
-
批准号:8669043
-
项目类别:
-
资助金额:$24.36万
-
财政年份:2010
-
负责人:Lu Wang
-
依托单位:
Vitamin D Status, Vitamin D Receptor Gene Variants, and Hypertension Risk
-
批准号:8534804
-
项目类别:
-
资助金额:$23.68万
-
财政年份:2010
-
负责人:Lu Wang
-
依托单位:
Vitamin D Status, Vitamin D Receptor Gene Variants, and Hypertension Risk
-
批准号:7989847
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2010
-
负责人:Lu Wang
-
依托单位:
Vitamin D Status, Vitamin D Receptor Gene Variants, and Hypertension Risk
-
批准号:8503656
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2010
-
负责人:Lu Wang
-
依托单位:
海外基金